Boai NKY Medical Holdings Ltd. (300109.SZ)
CNY 17.2
(6.57%)
CNY 17.2
(6.57%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 1.58 Billion | 1.48 Billion | 1.22 Billion | 978.52 Million | 924.42 Million | 698.28 Million |
| Cost of Revenue | 689.03 Million | 795.06 Million | 727.41 Million | 548.62 Million | 484 Million | 381.74 Million |
| Gross Profit | 894.38 Million | 690.63 Million | 492.86 Million | 429.9 Million | 440.42 Million | 316.53 Million |
| Operating Expenses | 309.15 Million | 254.97 Million | 333.26 Million | 270.77 Million | 208.54 Million | 164.33 Million |
| Selling, General and Administrative Expenses | 101.08 Million | 96.15 Million | 132.04 Million | 122.01 Million | 107.47 Million | 72.5 Million |
| Research and Development Expenses | 63.7 Million | 65.72 Million | 75.53 Million | 70.27 Million | 49.29 Million | 51.08 Million |
| Other Expenses | 1.1 Million | 93.09 Million | 125.69 Million | 78.48 Million | 51.78 Million | -1.5 Million |
| Cost and Expenses | 998.18 Million | 1.05 Billion | 1.06 Billion | 819.39 Million | 692.55 Million | 546.08 Million |
| Operating Income | 585.23 Million | 388.67 Million | 400.21 Million | 161.62 Million | 237.16 Million | 106.82 Million |
| Interest Expense | 2.99 Million | 2.61 Million | 37.73 Million | 51.56 Million | 48.95 Million | 33.59 Million |
| Income Tax Expense | 99.57 Million | 107.03 Million | 121.96 Million | 34.38 Million | 33.01 Million | 14.73 Million |
| Earnings before Tax | 585.36 Million | 388.46 Million | 402.85 Million | 67.02 Million | 158.76 Million | 105.31 Million |
| Net Income | 493.02 Million | 291.46 Million | 293.11 Million | 32.64 Million | 122.79 Million | 89.54 Million |
| Earnings Per Share Basic | 1.02 | 0.59 | 0.43 | 0.09 | 0.30 | 0.27 |
| Earnings Per Share Diluted | 0.97 | 0.57 | 0.41 | 0.09 | 0.30 | 0.27 |
| Weighted Average Shares Outstanding | 483.72 Million | 514.31 Million | 500.96 Million | 477.75 Million | 409.32 Million | 327.64 Million |
| Weighted Average Shares Outstanding (Diluted) | 506 Million | 514.31 Million | 500.96 Million | 477.75 Million | 409.32 Million | 327.64 Million |
| Gross Margin | 0.56 | 0.46 | 0.40 | 0.44 | 0.48 | 0.45 |
| EBIT Margin | 0.42 | 0.36 | 0.48 | 0.22 | 0.30 | 0.28 |
| Profit Margin | 0.31 | 0.20 | 0.24 | 0.03 | 0.13 | 0.13 |
| EBITDA | 665.28 Million | 460.5 Million | 409.02 Million | 171.04 Million | 250.71 Million | 178.11 Million |
| Earnings Before Tax Margin | 0.37 | 0.26 | 0.33 | 0.17 | 0.26 | 0.15 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 376.19 Million | 340.11 Million | 394.68 Million | 1.59 Billion | 383.61 Million | 427.51 Million |
| Cost of Revenue | 202.5 Million | 146.03 Million | 183.57 Million | 689.03 Million | 205.51 Million | 160.83 Million |
| Gross Profit | 173.68 Million | 194.07 Million | 211.11 Million | 901.11 Million | 178.1 Million | 266.68 Million |
| Operating Expenses | 54.91 Million | 76.03 Million | 61.07 Million | 977.17 Million | 287.84 Million | 76.17 Million |
| Selling, General and Administrative Expenses | 117.08 Million | 3.19 Million | 44.38 Million | - | -64.96 Million | 118.37 Million |
| Research and Development Expenses | 5.45 Million | 22.28 Million | 13.65 Million | - | 25.05 Million | 14.92 Million |
| Other Expenses | -67.62 Million | -2.56 Million | -450.31 Thousand | -977.17 Million | -287.84 Million | 1.2 Million |
| Cost and Expenses | 257.42 Million | 222.07 Million | 244.64 Million | 977.17 Million | 287.84 Million | 237.01 Million |
| Operating Income | 109.56 Million | 112.52 Million | 143.34 Million | 612.97 Million | 95.77 Million | 184.66 Million |
| Interest Expense | 1.07 Million | 1.29 Million | 1.12 Million | 2.06 Million | -975.53 Thousand | 1.08 Million |
| Income Tax Expense | 10.11 Million | 17.29 Million | 21.97 Million | 99.57 Million | -17.66 Million | 43.53 Million |
| Earnings before Tax | 108.5 Million | 109.96 Million | 142.89 Million | 614.12 Million | 95.22 Million | 185.87 Million |
| Net Income | 98.31 Million | 91.54 Million | 121.38 Million | 493.02 Million | 88.1 Million | 142.71 Million |
| Earnings Per Share Basic | 0.20 | 0.20 | 0.25 | - | 0.20 | 0.30 |
| Earnings Per Share Diluted | 0.20 | 0.19 | 0.25 | - | 0.18 | 0.29 |
| Weighted Average Shares Outstanding | 484.7 Million | 488.64 Million | 479.22 Million | 310.08 Million | 488.45 Million | 486.63 Million |
| Weighted Average Shares Outstanding (Diluted) | 484.7 Million | 488.63 Million | 479.22 Million | 324.36 Million | 488.45 Million | 486.63 Million |
| Gross Margin | 0.46 | 0.57 | 0.53 | 0.57 | 0.46 | 0.62 |
| EBIT Margin | 0.29 | 0.34 | 0.39 | - | 0.16 | 0.45 |
| Profit Margin | 0.26 | 0.27 | 0.31 | 0.31 | 0.23 | 0.33 |
| EBITDA | 109.58 Million | 116.33 Million | 153.56 Million | - | 63.25 Million | 192.24 Million |
| Earnings Before Tax Margin | 0.29 | 0.33 | 0.36 | 0.39 | 0.25 | 0.43 |
AVIFY
FRA
3833
ARVN
CPCAF
002792